KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Equity (2016 - 2025)

Vertex Pharmaceuticals (VRTX) has 16 years of Return on Equity data on record, last reported at 0.22% in Q4 2025.

  • For Q4 2025, Return on Equity rose 25.0% year-over-year to 0.22%; the TTM value through Dec 2025 reached 0.22%, up 25.0%, while the annual FY2025 figure was 0.23%, 26.0% up from the prior year.
  • Return on Equity reached 0.22% in Q4 2025 per VRTX's latest filing, up from 0.21% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.31% in Q1 2021 and bottomed at 0.06% in Q1 2025.
  • Average Return on Equity over 5 years is 0.18%, with a median of 0.22% recorded in 2024.
  • The widest YoY moves for Return on Equity: up 25bps in 2025, down -28bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.24% in 2021, then grew by 3bps to 0.25% in 2022, then decreased by -14bps to 0.21% in 2023, then crashed by -116bps to 0.03% in 2024, then soared by 757bps to 0.22% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.22% in Q4 2025, 0.21% in Q3 2025, and 0.22% in Q2 2025.